r21
Vaccineexperimental
R21, R-21 or R.21 may refer to: — Wikipedia
Clinical trial activity
26 trials · 30 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
14
Phase 3
2
Phase 4
3
Earliest trial started Sep 1, 2015 (NCT02572388)
Timeline
Indications
Approved for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07194668 | Phase 4 | Dec 1, 2025 | University of Oxford |
| NCT07183371 | Phase 2 | Nov 30, 2025 | European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Government of Germany, Institut et Haute école de la Santé, La Source, University of Oxford |
| NCT07074665 | Phase 2 | Oct 31, 2025 | Institut et Haute école de la Santé, La Source, University of Oxford |
| NCT06958198 | Phase 1 | Sep 15, 2025 | European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Government of Germany, Institut et Haute école de la Santé, La Source, University of Oxford, Wellcome Trust |
| NCT07147400 | Phase 2 | Aug 22, 2025 | National Institute of Allergy and Infectious Diseases (NIAID), Serum Institute of India Pvt. Ltd. |
| NCT06816524 | N/A | Jul 1, 2025 | Jomo Kenyatta University of Agriculture and Technology, National Institute for Public Health and the Environment, RIVM, Holland, Radboud University, Swiss Federal Institute of Technology |
| NCT06860178 | Phase 4 | Jun 10, 2025 | Epicentre, University of Liverpool |
| NCT06879327 | Phase 2 | May 30, 2025 | PATH, Pharmassist Ltd |
| NCT06080243 | Phase 2 | Feb 1, 2025 | European Vaccine Initiative (EVI), Heidelberg, Germany, Malaria Research and Training Center, Bamako, Mali, University of Oxford |
| NCT06507605 | Phase 1 | Jul 30, 2024 | National Institute of Allergy and Infectious Diseases (NIAID), Serum Institute of India Pvt. Ltd. |
| NCT06578572 | Phase 3 | May 30, 2024 | Institute Tropical Medicine Belgium and MRC Unit in The Gambia, National Malaria Control Programme, The Gambia, University of London |
| NCT06320535 | Phase 1 | Mar 25, 2024 | Bill and Melinda Gates Foundation, University Hospitals Bristol NHS Foundation Trust, University of Oxford |
| NCT06068530 | Phase 4 | Nov 1, 2023 | Mahidol University, University of Oxford |
| NCT05357560 | Phase 1 | Feb 28, 2023 | European and Developing Countries Clinical Trials Partnership (EDCTP), Medical Research Council, The Gambia, University of Oxford |
| NCT05252845 | Phase 2 | Jul 31, 2022 | Mahidol University, University of Oxford |
| NCT05385510 | Phase 1 | Jun 30, 2022 | Medical Research Council-UVRI Uganda Research Unit on AIDS, University of Oxford |
| NCT05155579 | Phase 1 | Feb 28, 2022 | Malaria Research and Training Center, Bamako, Mali, University of Oxford |
| NCT04704830 | Phase 3 | Apr 29, 2021 | Ifakara Health Institute, Institut et Haute école de la Santé, La Source, Malaria Research and Training Center, Bamako, Mali, Unité de recherche clinique de Nanoro (URCN), University of London, University of Oxford, Wellcome Trust |
| NCT03947190 | Phase 2 | Jul 31, 2019 | Kenya Medical Research Institute, University of Oxford |
| NCT03970993 | Phase 1/Phase 2 (Phase 2) | Jun 17, 2019 | University of Oxford |
Showing 20 of 26 trials
Page 1 / 2
Organizations
Research & Development (30)
30 organizations
Page 1 / 2